Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac for pain control after meniscus surgery
NCT04246541Phase 3Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Apr 2019
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ketorolac in postoperative pain, sponsored by University Hospitals Cleveland Medical Center. Primary endpoints: Visual Analogue Scale Pain Score at 2 weeks and Narcotic Medication Consumed at 5 days. Started Apr 2019; status: completed.
02
Drugs
ketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04246541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04246541.